The University of Chicago Header Logo

Connection

David Grdina to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications David Grdina has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
David Grdina
Connection Strength
0.006
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells. Exp Cell Res. 1992 Nov; 203(1):100-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.